Burning Rock Biotech Ltd (BNR)

NASDAQ
21.76
+2.09(+10.63%)
  • Volume:
    216,069
  • Bid/Ask:
    21.71/21.79
  • Day's Range:
    20.27 - 22.02

BNR Overview

Prev. Close
19.67
Day's Range
20.27-22.02
Revenue
72.37M
Open
20
52 wk Range
18.52-39.75
EPS
-0.84
Volume
216,069
Market Cap
2.06B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
373,446
P/E Ratio
-
Beta
-
1-Year Change
-27.2%
Shares Outstanding
121,873,337
Next Earnings Date
Nov 19, 2021
What is your sentiment on Burning Rock Biotech Ltd?
or
Vote to see community's results!

Burning Rock Biotech Ltd News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyBuySellStrong SellSell
Technical IndicatorsStrong BuyStrong BuySellStrong SellSell
SummaryStrong BuyStrong BuySellStrong SellSell

Burning Rock Biotech Ltd Company Profile

Burning Rock Biotech Ltd Company Profile

Employees
938

Burning Rock Biotech Ltd is a holding company mainly engaged in the next generation sequencing (NGS) based cancer therapy selection. The Company operates three segments. Central Laboratory Business segment is engaged in the sales of cancer therapy selection test to individual patients. In-Hospital Business segment is engaged in the sales of reagent kits and the provision of the facilitation services for the sale of laboratory equipment to hospitals. Pharma Research and Development Services segment provide services to companies primarily in relation to the development of targeted therapies and immunotherapies for various types of cancer, and to hospitals for their studies on cancer diagnosis and treatment. Its products include OncoScreen Plus and LungPlasma. Its NGS-based cancer therapy selection tests applicable to a broad range of cancer types, including lung cancer, prostate cancer, breast cancer and others. The Company mainly conducts its businesses in the China market.

Read More
  • why no one here
    0
    • why no one here
      0
      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.